BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 23968543)

  • 1. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
    Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
    Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
    Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
    Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis.
    McGarry T; Orr C; Wade S; Biniecka M; Wade S; Gallagher L; Low C; Veale DJ; Fearon U
    Arthritis Rheumatol; 2018 Dec; 70(12):1959-1970. PubMed ID: 29790294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors.
    Yarilina A; Xu K; Chan C; Ivashkiv LB
    Arthritis Rheum; 2012 Dec; 64(12):3856-66. PubMed ID: 22941906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
    Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
    Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
    Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis
    Palmroth M; Kuuliala K; Peltomaa R; Virtanen A; Kuuliala A; Kurttila A; Kinnunen A; Leirisalo-Repo M; Silvennoinen O; Isomäki P
    Front Immunol; 2021; 12():738481. PubMed ID: 34630419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function.
    O'Brien A; Hanlon MM; Marzaioli V; Wade SC; Flynn K; Fearon U; Veale DJ
    Front Immunol; 2021; 12():672461. PubMed ID: 34248953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
    Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
    Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
    Gao W; McGarry T; Orr C; McCormick J; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Jan; 75(1):311-5. PubMed ID: 26353790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium.
    Migita K; Koga T; Komori A; Torigoshi T; Maeda Y; Izumi Y; Sato J; Jiuchi Y; Miyashita T; Yamasaki S; Kawakami A; Nakamura M; Motokawa S; Ishibashi H
    J Rheumatol; 2011 Nov; 38(11):2309-17. PubMed ID: 21844139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of the Jak/STAT pathway.
    Aittomäki S; Pesu M
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):18-23. PubMed ID: 24164900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
    Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
    Front Immunol; 2019; 10():2056. PubMed ID: 31555281
    [No Abstract]   [Full Text] [Related]  

  • 14. Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway.
    Panipinto PM; Singh AK; Shaikh FS; Siegel RJ; Chourasia M; Ahmed S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.
    Muraoka S; Kusunoki N; Takahashi H; Tsuchiya K; Kawai S
    Clin Exp Rheumatol; 2013; 31(4):589-95. PubMed ID: 23622344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of moxibustion on JAK-STAT signal transduction pathways of synovial cells in rheumatoid arthritis rabbits].
    Yang X; Li JS; Yang SQ; Zhang XX; Zhang TS; Zhou HY; Liu XG
    Zhen Ci Yan Jiu; 2007 Apr; 32(2):75-82. PubMed ID: 17650648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib.
    Diller M; Hasseli R; Hülser ML; Aykara I; Frommer K; Rehart S; Müller-Ladner U; Neumann E
    Front Immunol; 2019; 10():541. PubMed ID: 30984167
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?
    Kour G; Choudhary R; Anjum S; Bhagat A; Bajaj BK; Ahmed Z
    Biochem Pharmacol; 2022 Mar; 197():114929. PubMed ID: 35065024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
    Orsolini G; Bertoldi I; Rossini M
    Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.